Document is current
Any future updates will be listed below
-
Authors
Hong, Huangming
Chen, Zegeng
Zhang, Mingzhi
Peng, Zhigang
Shen, Jianzhen
Shuang, Yuerong
Zhou, Hui
Guo, Hongqiang
Huang, He
Li, Fei
Qian, Zhengzi
Liu, Lihong
Wang, Liang
Yang, Wei
Zhang, Liling
He, Pengcheng
Qian, Shen
Li, Fugen
Li, Meng
Lin, Tongyu
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (82270198, 82470237)
Cancer Innovative Research Program of Sun Yat-sen University Cancer Center (CIRP-SYSUCC-0022)
- License Information
-
More Information
Article History
Received: 17 February 2025
Accepted: 3 April 2025
First Online: 27 April 2025
Declarations
:
: The study protocols received approval from the ethics committees at each participation center. All patients provided written informed consent, and the study adhered to the principles outlined in the Declaration of Helsinki. This study has been registered with ClinicalTrials.gov under the identifier NCT04390737.
: The authors declare no competing interests.
: NCT04390737
